Author

Khaled Alhamad

Observed name: K. Alhamad

Institutions: University of Utah, Huntsman Cancer Institute

Observed institutions: University of Utah, Allegheny General Hospital, Huntsman Cancer Institute

OpenAlex ID: A5086405200

Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma

2025 · Amin H. Nassar, Chul Kim, et al. · Nature Communications · 19

The use of immunotherapy treatment in malignant pheochromocytomas/paragangliomas: a case report

2021 · Robin Raquel Rodriguez, Saleha Rizwan, et al. · Journal of Medical Case Reports · 11

Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study

2025 · Frederique St-Pierre, Subodh Bhatta, et al. · Blood Cancer Journal · 9

An internal review of chemotherapy toxicities in patients with pancreatic cancer.

2021 · Karthik Shankar, Deanna Huffman, et al. · Journal of Clinical Oncology · 3

Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A real-world perspective.

2021 · Saleha Rizwan, Khaled Alhamad, et al. · Journal of Clinical Oncology · 2

Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Extranodal (EN) B-Cell Non-Hodgkin Lymphoma (NHL): Results from a Multicenter Analysis

2024 · Frederique St-Pierre, Subodh Bhatta, et al. · Blood · 1

A Multicenter Study Analyzing Survival and Prognostic Factors in Patients with Leukemic Phase Follicular Lymphoma

2023 · Asaad Trabolsi, Narendranath Epperla, et al. · Blood · 1

Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study

2024 · Asaad Trabolsi, Sunwoo Han, et al. · Blood Neoplasia

P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study

2024 · A.H. Nassar, K. Matteson, et al. · Journal of Thoracic Oncology

Impact of Immune-Related Adverse Events on Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Real-World Perspective

2024 · Saleha Rizwan, Maitreyee Rai, et al. · SSRN Electronic Journal

Outcomes in primary gastrointestinal (GI) follicular lymphoma (FL): results from a multicenter analysis

2023 · F. St‐Pierre, T. Alrifai, et al. · Hematological Oncology

Comparison of survival outcomes with the use of combination chemoimmunotherapy versus immunotherapy alone in NSCLC with high PD-L1 expression.

2021 · Saleha Rizwan, Khaled Alhamad, et al. · Journal of Clinical Oncology

Surgical outcomes and rate of pathological response in resectable/borderline resectable pancreatic cancer patients undergoing neoadjuvant gemcitabine/nab-paclitaxel versus FOLFIRINOX: A retrospective institutional analysis.

2021 · Abraham Attah Attah, Saleha Rizwan, et al. · Journal of Clinical Oncology

Neoadjuvant chemotherapy and disease recurrence after curative-intent surgery in patients with pancreatic adenocarcinoma: A single-center retrospective review.

2021 · Khaled Alhamad, Nada Alrifai, et al. · Journal of Clinical Oncology

Works count: 14

Citation count: 46

H-index: 3

I10-index: 2